| Dr Kathryn G Wadland, MD | |
|
195 Fore River Pkwy, Suite 440, Portland, ME 04102-2780 | |
| (207) 553-6920 | |
| (207) 553-6940 |
| Full Name | Dr Kathryn G Wadland |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 195 Fore River Pkwy, Portland, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104994805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 017376 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Light Mercy Hospital | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Hospital | 6103737812 | 207 |
News Archive
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
Scientists at Western University have identified a new therapeutic target for advanced breast cancer which has shown tremendous promise in mouse models.
Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies' antibody-drug conjugate (ADC) collaboration. Under the amended agreement, Agensys will pay a $12 million fee for exclusive rights to ADC licenses against additional antigen targets. Seattle Genetics also receives an option to co-develop another ADC at the time of investigational new drug (IND) submission.
The Medical Research Council (MRC) has launched a Call for Proposals in experimental medicine today as part of its £15 million commitment to promote the translation of laboratory research into clinical practice for the benefit of patients.
› Verified 2 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
Scientists at Western University have identified a new therapeutic target for advanced breast cancer which has shown tremendous promise in mouse models.
Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies' antibody-drug conjugate (ADC) collaboration. Under the amended agreement, Agensys will pay a $12 million fee for exclusive rights to ADC licenses against additional antigen targets. Seattle Genetics also receives an option to co-develop another ADC at the time of investigational new drug (IND) submission.
The Medical Research Council (MRC) has launched a Call for Proposals in experimental medicine today as part of its £15 million commitment to promote the translation of laboratory research into clinical practice for the benefit of patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kathryn G Wadland, MD 195 Fore River Pkwy, Suite 440, Portland, ME 04102-2780 Ph: (207) 553-6920 | Dr Kathryn G Wadland, MD 195 Fore River Pkwy, Suite 440, Portland, ME 04102-2780 Ph: (207) 553-6920 |
News Archive
Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.
Scientists at Western University have identified a new therapeutic target for advanced breast cancer which has shown tremendous promise in mouse models.
Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies' antibody-drug conjugate (ADC) collaboration. Under the amended agreement, Agensys will pay a $12 million fee for exclusive rights to ADC licenses against additional antigen targets. Seattle Genetics also receives an option to co-develop another ADC at the time of investigational new drug (IND) submission.
The Medical Research Council (MRC) has launched a Call for Proposals in experimental medicine today as part of its £15 million commitment to promote the translation of laboratory research into clinical practice for the benefit of patients.
› Verified 2 days ago
Carol M Vaughan, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 84 Marginal Way, Suite 900, Portland, ME 04101 Phone: 207-874-2445 Fax: 207-523-8598 | |
Toby M Fitzgerald, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 887 Congress St Ste 200, Portland, ME 04102 Phone: 207-771-5549 Fax: 207-771-7834 | |
Dr. Edward Bumno Yoon, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 895 Washington Ave, Portland, ME 04103 Phone: 207-791-3888 | |
Anne Marie Van Hengel, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 84 Marginal Way, Suite 900, Portland, ME 04101 Phone: 207-874-2445 Fax: 207-523-8598 | |
Dr. Debra K Sepulveda, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 Fax: 207-662-6219 | |
Mary Anne Carroll, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Maine Medical Center, 22 Bramhall Street, Portland, ME 04102 Phone: 207-662-0111 |